Farmak JSC

About us

Farmak is the leader of Ukrainian pharmaceutical market with a share of 5.9 % with more than 95 years history. The medicines of all 14 therapeutic groups are produced at the factory and exported to CIS countries, Baltic States, Germany, Bulgaria, Poland, Vietnam, Mexica and MENA region etc. which is 20% of all company sales.
The company's mission is to make treatment with modern effective medicines available, helping people to be healthy and happy. In 2019, 20 new products were introduced into production. Farmak has expanded anti-cold, allergological, neurological, gastroenterological product portfolios and released medications in a new pulmonological portfolio. The company's portfolio of products includes more than 130 products.
The company annually reinvests about 95% of its profit in development. Over the last 5 years, Farmak has invested USD 120 million in scientific and technical complex, production equipment and research activities. The expansion of production over the past 5 years has allowed to increase the amount of manufactured products by 35%. In 2015, Farmak opened its own production of substances in Shostka. Approximately 20% of the company's pharmaceutical substances are manufactured at the plant; this indicates the vertical integration of Farmak. All manufacturing lines are GMP certified by Ukrainian governmental inspection according to PIC/S and by European authorities from Poland, Croatia and Germany.
The introduction of modern technologies, advanced equipment and innovative approaches in the production and management activities of Farmak is a long-standing ideology of the company and its main competitive advantage.
As a right partner Farmak is open for various types of cooperation, such as export of our products in inished dosage forms as well as in-bulk (unlabeled), in- and out-licensing, contract manufacturing including R&D and technologies transfer and always looking for new possibilities.

Specs about this supplier

Products featured at CPhI South East Asia 2021